• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

8. 肥胖和体重管理以预防和治疗 2 型糖尿病:2023 年糖尿病护理标准。

8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2023.

出版信息

Diabetes Care. 2023 Jan 1;46(Suppl 1):S128-S139. doi: 10.2337/dc23-S008.

DOI:10.2337/dc23-S008
PMID:36507637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9810466/
Abstract

The American Diabetes Association (ADA) "Standards of Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

摘要

美国糖尿病协会(ADA)的“糖尿病标准护理”包括 ADA 当前的临床实践建议,旨在提供糖尿病护理的组成部分、一般治疗目标和指南,以及评估护理质量的工具。ADA 专业实践委员会的成员是一个多学科专家委员会,负责每年更新标准护理,或根据需要更频繁地更新。有关 ADA 标准、声明和报告的详细描述,以及 ADA 临床实践建议的证据分级系统和专业实践委员会成员的完整列表,请参阅简介和方法。希望对标准护理发表意见的读者可在 professional.diabetes.org/SOC 上发表意见。

相似文献

1
8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2023.8. 肥胖和体重管理以预防和治疗 2 型糖尿病:2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S128-S139. doi: 10.2337/dc23-S008.
2
8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2024.8. 肥胖与体重管理在2型糖尿病预防和治疗中的应用:2024年糖尿病照护标准
Diabetes Care. 2024 Jan 1;47(Suppl 1):S145-S157. doi: 10.2337/dc24-S008.
3
8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2022.8. 肥胖与体重管理以预防和治疗 2 型糖尿病:2022 年糖尿病医学诊疗标准。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S113-S124. doi: 10.2337/dc22-S008.
4
3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2023.3. 2 型糖尿病及其合并症的预防或延缓:2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S41-S48. doi: 10.2337/dc23-S003.
5
6. Glycemic Targets: Standards of Care in Diabetes-2023.6. 血糖目标:2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S97-S110. doi: 10.2337/dc23-S006.
6
17. Diabetes Advocacy: Standards of Care in Diabetes-2023.17. 糖尿病倡导:2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S279-S280. doi: 10.2337/dc23-S017.
7
7. Diabetes Technology: Standards of Care in Diabetes-2023.7. 糖尿病技术:2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S111-S127. doi: 10.2337/dc23-S007.
8
16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2023.16. 医院中的糖尿病护理:2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S267-S278. doi: 10.2337/dc23-S016.
9
13. Older Adults: Standards of Care in Diabetes-2023.13. 老年人:2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S216-S229. doi: 10.2337/dc23-S013.
10
15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes-2023.15. 妊娠糖尿病管理:2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S254-S266. doi: 10.2337/dc23-S015.

引用本文的文献

1
Improvement in body mass index category was associated with improved cardiometabolic measures and patient-reported outcomes in adults with type 2 diabetes treated with tirzepatide.在接受替尔泊肽治疗的2型糖尿病成人患者中,体重指数类别改善与心脏代谢指标改善及患者报告的结局相关。
Diabetes Obes Metab. 2025 Oct;27(10):5694-5705. doi: 10.1111/dom.16620. Epub 2025 Jul 24.
2
Harnessing animal model and computational experiments to discover antidiabetic compounds in Ficus racemosa.利用动物模型和计算实验发现聚果榕中的抗糖尿病化合物。
BMC Complement Med Ther. 2025 Jul 2;25(1):215. doi: 10.1186/s12906-025-04845-7.
3
International expert consensus on surgery for type 2 diabetes mellitus.2型糖尿病手术治疗的国际专家共识
BMC Endocr Disord. 2025 Jul 1;25(1):151. doi: 10.1186/s12902-025-01961-w.
4
Bidirectional Interactions Between the Gut Microbiota and Incretin-Based Therapies.肠道微生物群与基于肠促胰岛素的疗法之间的双向相互作用。
Life (Basel). 2025 May 23;15(6):843. doi: 10.3390/life15060843.
5
Efficacy of Anti-Obesity Medications in Adult and Older Adult Veteran Populations.抗肥胖药物在成年及老年退伍军人人群中的疗效。
Fed Pract. 2025 Feb;42(2):90-94. doi: 10.12788/fp.0553. Epub 2025 Feb 15.
6
The experiences of night shift workers following three different dietary weight loss interventions: a qualitative study using behaviour change theory.三种不同饮食减肥干预措施下夜班工作者的经历:一项运用行为改变理论的定性研究
Int J Behav Nutr Phys Act. 2025 May 28;22(1):64. doi: 10.1186/s12966-025-01750-7.
7
Risk factors associated with non-communicable diseases among government employees in Nepal: insights from a cross-sectional study.尼泊尔政府雇员中非传染性疾病的相关风险因素:一项横断面研究的见解
Front Public Health. 2025 May 9;13:1514807. doi: 10.3389/fpubh.2025.1514807. eCollection 2025.
8
Perspectives of type 2 diabetes mellitus management in Algeria: a comprehensive expert review.阿尔及利亚2型糖尿病管理的现状:一项全面的专家综述。
Front Clin Diabetes Healthc. 2025 Apr 15;6:1495849. doi: 10.3389/fcdhc.2025.1495849. eCollection 2025.
9
Nutrition Interventions for Remission of Type 2 Diabetes: Potential Role for Diabetes-Specific Nutrition Formulas.用于2型糖尿病缓解的营养干预措施:糖尿病专用营养配方的潜在作用
Clin Diabetes. 2024 Oct 28;43(2):291-302. doi: 10.2337/cd24-0052. eCollection 2025 Spring.
10
Ketogenic Diets for Body Weight Loss: A Comparison with Other Diets.用于减肥的生酮饮食:与其他饮食的比较
Nutrients. 2025 Mar 10;17(6):965. doi: 10.3390/nu17060965.

本文引用的文献

1
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial.新型双重 GIP 和 GLP-1 受体激动剂替西帕肽在 2 型糖尿病患者中的疗效和安全性(SURPASS-1):一项双盲、随机、3 期临床试验。
Lancet. 2021 Jul 10;398(10295):143-155. doi: 10.1016/S0140-6736(21)01324-6. Epub 2021 Jun 27.
2
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.替尔泊肽与司美格鲁肽每周一次治疗 2 型糖尿病患者的疗效比较。
N Engl J Med. 2021 Aug 5;385(6):503-515. doi: 10.1056/NEJMoa2107519. Epub 2021 Jun 25.
3
A Systematic Review of Dietary Supplements and Alternative Therapies for Weight Loss.膳食补充剂和替代疗法减肥的系统评价。
Obesity (Silver Spring). 2021 Jul;29(7):1102-1113. doi: 10.1002/oby.23110.
4
Efficacy of dietary supplements containing isolated organic compounds for weight loss: a systematic review and meta-analysis of randomised placebo-controlled trials.含单一有机化合物的膳食补充剂对减肥的疗效:随机安慰剂对照试验的系统评价和荟萃分析
Int J Obes (Lond). 2021 Aug;45(8):1631-1643. doi: 10.1038/s41366-021-00839-w. Epub 2021 May 11.
5
Glycemic Patterns Are Distinct in Post-Bariatric Hypoglycemia After Gastric Bypass (PBH-RYGB).胃旁路术后(PBH-RYGB)后低血糖的血糖模式存在差异。
J Clin Endocrinol Metab. 2021 Jul 13;106(8):2291-2303. doi: 10.1210/clinem/dgab323.
6
Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants.代谢性减重手术与有或无糖尿病成人长期生存的关联:一项对 174772 名参与者的匹配队列和前瞻性对照研究的一阶段荟萃分析。
Lancet. 2021 May 15;397(10287):1830-1841. doi: 10.1016/S0140-6736(21)00591-2. Epub 2021 May 6.
7
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial.司美格鲁肽 2·4 毫克每周一次治疗超重或肥胖、以及 2 型糖尿病成人患者(STEP 2):一项随机、双盲、双模拟、安慰剂对照、3 期临床试验。
Lancet. 2021 Mar 13;397(10278):971-984. doi: 10.1016/S0140-6736(21)00213-0. Epub 2021 Mar 2.
8
Obesity and COVID-19 in Adult Patients With Diabetes.肥胖与糖尿病成人患者的 COVID-19。
Diabetes. 2021 May;70(5):1061-1069. doi: 10.2337/db20-0671. Epub 2021 Feb 17.
9
Obesity is associated with increased severity of disease in COVID-19 pneumonia: a systematic review and meta-analysis.肥胖与 COVID-19 肺炎疾病严重程度增加相关:系统评价和荟萃分析。
Eur J Med Res. 2020 Dec 2;25(1):64. doi: 10.1186/s40001-020-00464-9.
10
Hypoglycemia After Upper Gastrointestinal Surgery: Clinical Approach to Assessment, Diagnosis, and Treatment.上消化道手术后低血糖症:评估、诊断及治疗的临床方法
Diabetes Metab Syndr Obes. 2020 Nov 19;13:4469-4482. doi: 10.2147/DMSO.S233078. eCollection 2020.